Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks

Stopped early · Phase 4

Conditions studied: Medical Abortion

In brief

This study seeks to evaluate the efficacy, side effect profile and acceptability of a medical abortion regimen with mifepristone and two doses of 800 mcg misoprostol buccally at 71-77 and 78-84 days of gestation to further expand the evidence base for the most effective regimens in the late first trimester of pregnancy.

Key facts

Study ID
NCT05119439
Run by
Gynuity Health Projects
People needed
23
Starts
2022-10-07
Expected to finish
2023-06-30
Last updated by the study team
2023-07-25

Who can join

Age: 11 and older, up to 55. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.